Drug intelligence / Profile preview

human rabies immune globulin + rabies vaccine

Development stage
Unknown
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Infiltration (hrig: Into/around, If Wound Present)
01

Overview

**Human rabies immune globulin + rabies vaccine** is a combination used for post-exposure prophylaxis following suspected exposure to rabies in individuals without prior vaccination. Human rabies immune globulin (HRIG) provides immediate, passive antibodies against the rabies virus, neutralizing the pathogen at the wound site until the body mounts its own immune response. The rabies vaccine triggers active antibody production, conferring long-term immunity. The immune globulin is administered infiltrated around the wound and any remainder intramuscularly, while the vaccine is given intramuscularly at a separate anatomical site. This combination is the recommended standard of care for post-exposure prophylaxis in non-immunized persons and immunocompromised patients[2][3][6].

Brand names
Hyperrab + RabavertImogam + ImovaxKedrab + rabies vaccine
Other names
HRIG + rabies vaccinehuman rabies immunoglobulin + rabies vaccine
02

Targets

RABV-G (Rabies virus glycoprotein)

Beyond the preview

Go deeper on human rabies immune globulin + rabies vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human rabies immune globulin + rabies vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call